Issue 59, 2020

An MRI-visible immunoadjuvant based on hollow Gd2O3 nanospheres for cancer immunotherapy

Abstract

Hollow Gd2O3 nanospheres significantly promote the cellular uptake of a tumor antigen by antigen presenting cells, exhibit pH-dependent alteration of the MR signal intensity and markedly enhance the antitumor immunity. Hollow Gd2O3 nanospheres are promising as magnetic resonance imaging (MRI)-visible cancer immunoadjuvants for cancer immunotherapy.

Graphical abstract: An MRI-visible immunoadjuvant based on hollow Gd2O3 nanospheres for cancer immunotherapy

Supplementary files

Article information

Article type
Communication
Submitted
19 May 2020
Accepted
22 Jun 2020
First published
22 Jun 2020

Chem. Commun., 2020,56, 8186-8189

An MRI-visible immunoadjuvant based on hollow Gd2O3 nanospheres for cancer immunotherapy

X. Li, X. Wang and A. Ito, Chem. Commun., 2020, 56, 8186 DOI: 10.1039/D0CC03568H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements